Global Generic Peptides Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Generic Peptides Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Generic Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Hormone Analogs
  • 1.2.3 Vasopressin Analogs
  • 1.2.4 Calcitonin Generics
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Generic Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Commercial Production
  • 1.3.3 Scientific Research
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Generic Peptides Sales Estimates and Forecasts 2018-2029
• 2.2 Global Generic Peptides Revenue by Region
  • 2.2.1 Global Generic Peptides Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Generic Peptides Revenue by Region (2018-2023)
  • 2.2.3 Global Generic Peptides Revenue by Region (2024-2029)
  • 2.2.4 Global Generic Peptides Revenue Market Share by Region (2018-2029)
• 2.3 Global Generic Peptides Sales Estimates and Forecasts 2018-2029
• 2.4 Global Generic Peptides Sales by Region
  • 2.4.1 Global Generic Peptides Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Generic Peptides Sales by Region (2018-2023)
  • 2.4.3 Global Generic Peptides Sales by Region (2024-2029)
  • 2.4.4 Global Generic Peptides Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Generic Peptides Sales by Manufacturers
  • 3.1.1 Global Generic Peptides Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Generic Peptides Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Generic Peptides in 2022
• 3.2 Global Generic Peptides Revenue by Manufacturers
  • 3.2.1 Global Generic Peptides Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Generic Peptides Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Generic Peptides Revenue in 2022
• 3.3 Global Key Players of Generic Peptides, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Generic Peptides Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Generic Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Generic Peptides, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Generic Peptides, Product Offered and Application
• 3.8 Global Key Manufacturers of Generic Peptides, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Generic Peptides Sales by Type
  • 4.1.1 Global Generic Peptides Historical Sales by Type (2018-2023)
  • 4.1.2 Global Generic Peptides Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Generic Peptides Sales Market Share by Type (2018-2029)
• 4.2 Global Generic Peptides Revenue by Type
  • 4.2.1 Global Generic Peptides Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Generic Peptides Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Generic Peptides Revenue Market Share by Type (2018-2029)
• 4.3 Global Generic Peptides Price by Type
  • 4.3.1 Global Generic Peptides Price by Type (2018-2023)
  • 4.3.2 Global Generic Peptides Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Generic Peptides Sales by Application
  • 5.1.1 Global Generic Peptides Historical Sales by Application (2018-2023)
  • 5.1.2 Global Generic Peptides Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Generic Peptides Sales Market Share by Application (2018-2029)
• 5.2 Global Generic Peptides Revenue by Application
  • 5.2.1 Global Generic Peptides Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Generic Peptides Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Generic Peptides Revenue Market Share by Application (2018-2029)
• 5.3 Global Generic Peptides Price by Application
  • 5.3.1 Global Generic Peptides Price by Application (2018-2023)
  • 5.3.2 Global Generic Peptides Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Generic Peptides Market Size by Type
  • 6.1.1 US & Canada Generic Peptides Sales by Type (2018-2029)
  • 6.1.2 US & Canada Generic Peptides Revenue by Type (2018-2029)
• 6.2 US & Canada Generic Peptides Market Size by Application
  • 6.2.1 US & Canada Generic Peptides Sales by Application (2018-2029)
  • 6.2.2 US & Canada Generic Peptides Revenue by Application (2018-2029)
• 6.3 US & Canada Generic Peptides Market Size by Country
  • 6.3.1 US & Canada Generic Peptides Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Generic Peptides Sales by Country (2018-2029)
  • 6.3.3 US & Canada Generic Peptides Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Generic Peptides Market Size by Type
  • 7.1.1 Europe Generic Peptides Sales by Type (2018-2029)
  • 7.1.2 Europe Generic Peptides Revenue by Type (2018-2029)
• 7.2 Europe Generic Peptides Market Size by Application
  • 7.2.1 Europe Generic Peptides Sales by Application (2018-2029)
  • 7.2.2 Europe Generic Peptides Revenue by Application (2018-2029)
• 7.3 Europe Generic Peptides Market Size by Country
  • 7.3.1 Europe Generic Peptides Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Generic Peptides Sales by Country (2018-2029)
  • 7.3.3 Europe Generic Peptides Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Generic Peptides Market Size
  • 8.1.1 China Generic Peptides Sales (2018-2029)
  • 8.1.2 China Generic Peptides Revenue (2018-2029)
• 8.2 China Generic Peptides Market Size by Application
  • 8.2.1 China Generic Peptides Sales by Application (2018-2029)
  • 8.2.2 China Generic Peptides Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Generic Peptides Market Size by Type
  • 9.1.1 Asia Generic Peptides Sales by Type (2018-2029)
  • 9.1.2 Asia Generic Peptides Revenue by Type (2018-2029)
• 9.2 Asia Generic Peptides Market Size by Application
  • 9.2.1 Asia Generic Peptides Sales by Application (2018-2029)
  • 9.2.2 Asia Generic Peptides Revenue by Application (2018-2029)
• 9.3 Asia Generic Peptides Sales by Region
  • 9.3.1 Asia Generic Peptides Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Generic Peptides Revenue by Region (2018-2029)
  • 9.3.3 Asia Generic Peptides Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Generic Peptides Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Generic Peptides Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Generic Peptides Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Generic Peptides Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Generic Peptides Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Generic Peptides Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Generic Peptides Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Generic Peptides Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Generic Peptides Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Generic Peptides Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Bachem
  • 11.1.1 Bachem Company Information
  • 11.1.2 Bachem Overview
  • 11.1.3 Bachem Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Bachem Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Bachem Recent Developments
• 11.2 PolyPeptide
  • 11.2.1 PolyPeptide Company Information
  • 11.2.2 PolyPeptide Overview
  • 11.2.3 PolyPeptide Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 PolyPeptide Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 PolyPeptide Recent Developments
• 11.3 AmbioPharm
  • 11.3.1 AmbioPharm Company Information
  • 11.3.2 AmbioPharm Overview
  • 11.3.3 AmbioPharm Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 AmbioPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 AmbioPharm Recent Developments
• 11.4 CordenPharma
  • 11.4.1 CordenPharma Company Information
  • 11.4.2 CordenPharma Overview
  • 11.4.3 CordenPharma Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 CordenPharma Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 CordenPharma Recent Developments
• 11.5 USV Peptides
  • 11.5.1 USV Peptides Company Information
  • 11.5.2 USV Peptides Overview
  • 11.5.3 USV Peptides Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 USV Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 USV Peptides Recent Developments
• 11.6 ScinoPharm
  • 11.6.1 ScinoPharm Company Information
  • 11.6.2 ScinoPharm Overview
  • 11.6.3 ScinoPharm Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 ScinoPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 ScinoPharm Recent Developments
• 11.7 Piramal Pharma Solutions
  • 11.7.1 Piramal Pharma Solutions Company Information
  • 11.7.2 Piramal Pharma Solutions Overview
  • 11.7.3 Piramal Pharma Solutions Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Piramal Pharma Solutions Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Piramal Pharma Solutions Recent Developments
• 11.8 CPC Scientific
  • 11.8.1 CPC Scientific Company Information
  • 11.8.2 CPC Scientific Overview
  • 11.8.3 CPC Scientific Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 CPC Scientific Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 CPC Scientific Recent Developments
• 11.9 Dr. Reddy's Laboratories
  • 11.9.1 Dr. Reddy's Laboratories Company Information
  • 11.9.2 Dr. Reddy's Laboratories Overview
  • 11.9.3 Dr. Reddy's Laboratories Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 Dr. Reddy's Laboratories Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Dr. Reddy's Laboratories Recent Developments
• 11.10 Omgene Life Sciences
  • 11.10.1 Omgene Life Sciences Company Information
  • 11.10.2 Omgene Life Sciences Overview
  • 11.10.3 Omgene Life Sciences Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 Omgene Life Sciences Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Omgene Life Sciences Recent Developments
• 11.11 ANYGEN
  • 11.11.1 ANYGEN Company Information
  • 11.11.2 ANYGEN Overview
  • 11.11.3 ANYGEN Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.11.4 ANYGEN Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 ANYGEN Recent Developments
• 11.12 BCN Peptides
  • 11.12.1 BCN Peptides Company Information
  • 11.12.2 BCN Peptides Overview
  • 11.12.3 BCN Peptides Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.12.4 BCN Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 BCN Peptides Recent Developments
• 11.13 Amphastar Pharmaceuticals
  • 11.13.1 Amphastar Pharmaceuticals Company Information
  • 11.13.2 Amphastar Pharmaceuticals Overview
  • 11.13.3 Amphastar Pharmaceuticals Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.13.4 Amphastar Pharmaceuticals Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Amphastar Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Generic Peptides Industry Chain Analysis
• 12.2 Generic Peptides Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Generic Peptides Production Mode & Process
• 12.4 Generic Peptides Sales and Marketing
  • 12.4.1 Generic Peptides Sales Channels
  • 12.4.2 Generic Peptides Distributors
• 12.5 Generic Peptides Customers

13 Market Dynamics

• 13.1 Generic Peptides Industry Trends
• 13.2 Generic Peptides Market Drivers
• 13.3 Generic Peptides Market Challenges
• 13.4 Generic Peptides Market Restraints

14 Key Findings in The Global Generic Peptides Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Generic Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Hormone Analogs
• Table 3. Major Manufacturers of Vasopressin Analogs
• Table 4. Major Manufacturers of Calcitonin Generics
• Table 5. Major Manufacturers of Other
• Table 6. Global Generic Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 7. Global Generic Peptides Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 8. Global Generic Peptides Revenue by Region (2018-2023) & (US$ Million)
• Table 9. Global Generic Peptides Revenue by Region (2024-2029) & (US$ Million)
• Table 10. Global Generic Peptides Revenue Market Share by Region (2018-2023)
• Table 11. Global Generic Peptides Revenue Market Share by Region (2024-2029)
• Table 12. Global Generic Peptides Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 13. Global Generic Peptides Sales by Region (2018-2023) & (K Units)
• Table 14. Global Generic Peptides Sales by Region (2024-2029) & (K Units)
• Table 15. Global Generic Peptides Sales Market Share by Region (2018-2023)
• Table 16. Global Generic Peptides Sales Market Share by Region (2024-2029)
• Table 17. Global Generic Peptides Sales by Manufacturers (2018-2023) & (K Units)
• Table 18. Global Generic Peptides Sales Share by Manufacturers (2018-2023)
• Table 19. Global Generic Peptides Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 20. Global Generic Peptides Revenue Share by Manufacturers (2018-2023)
• Table 21. Global Key Players of Generic Peptides, Industry Ranking, 2021 VS 2022 VS 2023
• Table 22. Generic Peptides Price by Manufacturers 2018-2023 (US$/Unit)
• Table 23. Global Generic Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 24. Global Generic Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Peptides as of 2022)
• Table 25. Global Key Manufacturers of Generic Peptides, Manufacturing Base Distribution and Headquarters
• Table 26. Global Key Manufacturers of Generic Peptides, Product Offered and Application
• Table 27. Global Key Manufacturers of Generic Peptides, Date of Enter into This Industry
• Table 28. Mergers & Acquisitions, Expansion Plans
• Table 29. Global Generic Peptides Sales by Type (2018-2023) & (K Units)
• Table 30. Global Generic Peptides Sales by Type (2024-2029) & (K Units)
• Table 31. Global Generic Peptides Sales Share by Type (2018-2023)
• Table 32. Global Generic Peptides Sales Share by Type (2024-2029)
• Table 33. Global Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
• Table 34. Global Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
• Table 35. Global Generic Peptides Revenue Share by Type (2018-2023)
• Table 36. Global Generic Peptides Revenue Share by Type (2024-2029)
• Table 37. Generic Peptides Price by Type (2018-2023) & (US$/Unit)
• Table 38. Global Generic Peptides Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 39. Global Generic Peptides Sales by Application (2018-2023) & (K Units)
• Table 40. Global Generic Peptides Sales by Application (2024-2029) & (K Units)
• Table 41. Global Generic Peptides Sales Share by Application (2018-2023)
• Table 42. Global Generic Peptides Sales Share by Application (2024-2029)
• Table 43. Global Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
• Table 44. Global Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
• Table 45. Global Generic Peptides Revenue Share by Application (2018-2023)
• Table 46. Global Generic Peptides Revenue Share by Application (2024-2029)
• Table 47. Generic Peptides Price by Application (2018-2023) & (US$/Unit)
• Table 48. Global Generic Peptides Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 49. US & Canada Generic Peptides Sales by Type (2018-2023) & (K Units)
• Table 50. US & Canada Generic Peptides Sales by Type (2024-2029) & (K Units)
• Table 51. US & Canada Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
• Table 52. US & Canada Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
• Table 53. US & Canada Generic Peptides Sales by Application (2018-2023) & (K Units)
• Table 54. US & Canada Generic Peptides Sales by Application (2024-2029) & (K Units)
• Table 55. US & Canada Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
• Table 56. US & Canada Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
• Table 57. US & Canada Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 58. US & Canada Generic Peptides Revenue by Country (2018-2023) & (US$ Million)
• Table 59. US & Canada Generic Peptides Revenue by Country (2024-2029) & (US$ Million)
• Table 60. US & Canada Generic Peptides Sales by Country (2018-2023) & (K Units)
• Table 61. US & Canada Generic Peptides Sales by Country (2024-2029) & (K Units)
• Table 62. Europe Generic Peptides Sales by Type (2018-2023) & (K Units)
• Table 63. Europe Generic Peptides Sales by Type (2024-2029) & (K Units)
• Table 64. Europe Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
• Table 65. Europe Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
• Table 66. Europe Generic Peptides Sales by Application (2018-2023) & (K Units)
• Table 67. Europe Generic Peptides Sales by Application (2024-2029) & (K Units)
• Table 68. Europe Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
• Table 69. Europe Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
• Table 70. Europe Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 71. Europe Generic Peptides Revenue by Country (2018-2023) & (US$ Million)
• Table 72. Europe Generic Peptides Revenue by Country (2024-2029) & (US$ Million)
• Table 73. Europe Generic Peptides Sales by Country (2018-2023) & (K Units)
• Table 74. Europe Generic Peptides Sales by Country (2024-2029) & (K Units)
• Table 75. China Generic Peptides Sales by Type (2018-2023) & (K Units)
• Table 76. China Generic Peptides Sales by Type (2024-2029) & (K Units)
• Table 77. China Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
• Table 78. China Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
• Table 79. China Generic Peptides Sales by Application (2018-2023) & (K Units)
• Table 80. China Generic Peptides Sales by Application (2024-2029) & (K Units)
• Table 81. China Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
• Table 82. China Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
• Table 83. Asia Generic Peptides Sales by Type (2018-2023) & (K Units)
• Table 84. Asia Generic Peptides Sales by Type (2024-2029) & (K Units)
• Table 85. Asia Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
• Table 86. Asia Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
• Table 87. Asia Generic Peptides Sales by Application (2018-2023) & (K Units)
• Table 88. Asia Generic Peptides Sales by Application (2024-2029) & (K Units)
• Table 89. Asia Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
• Table 90. Asia Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
• Table 91. Asia Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 92. Asia Generic Peptides Revenue by Region (2018-2023) & (US$ Million)
• Table 93. Asia Generic Peptides Revenue by Region (2024-2029) & (US$ Million)
• Table 94. Asia Generic Peptides Sales by Region (2018-2023) & (K Units)
• Table 95. Asia Generic Peptides Sales by Region (2024-2029) & (K Units)
• Table 96. Middle East, Africa and Latin America Generic Peptides Sales by Type (2018-2023) & (K Units)
• Table 97. Middle East, Africa and Latin America Generic Peptides Sales by Type (2024-2029) & (K Units)
• Table 98. Middle East, Africa and Latin America Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
• Table 100. Middle East, Africa and Latin America Generic Peptides Sales by Application (2018-2023) & (K Units)
• Table 101. Middle East, Africa and Latin America Generic Peptides Sales by Application (2024-2029) & (K Units)
• Table 102. Middle East, Africa and Latin America Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 105. Middle East, Africa and Latin America Generic Peptides Revenue by Country (2018-2023) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Generic Peptides Revenue by Country (2024-2029) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Generic Peptides Sales by Country (2018-2023) & (K Units)
• Table 108. Middle East, Africa and Latin America Generic Peptides Sales by Country (2024-2029) & (K Units)
• Table 109. Bachem Company Information
• Table 110. Bachem Description and Major Businesses
• Table 111. Bachem Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 112. Bachem Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 113. Bachem Recent Developments
• Table 114. PolyPeptide Company Information
• Table 115. PolyPeptide Description and Major Businesses
• Table 116. PolyPeptide Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 117. PolyPeptide Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 118. PolyPeptide Recent Developments
• Table 119. AmbioPharm Company Information
• Table 120. AmbioPharm Description and Major Businesses
• Table 121. AmbioPharm Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 122. AmbioPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 123. AmbioPharm Recent Developments
• Table 124. CordenPharma Company Information
• Table 125. CordenPharma Description and Major Businesses
• Table 126. CordenPharma Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 127. CordenPharma Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 128. CordenPharma Recent Developments
• Table 129. USV Peptides Company Information
• Table 130. USV Peptides Description and Major Businesses
• Table 131. USV Peptides Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 132. USV Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 133. USV Peptides Recent Developments
• Table 134. ScinoPharm Company Information
• Table 135. ScinoPharm Description and Major Businesses
• Table 136. ScinoPharm Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 137. ScinoPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 138. ScinoPharm Recent Developments
• Table 139. Piramal Pharma Solutions Company Information
• Table 140. Piramal Pharma Solutions Description and Major Businesses
• Table 141. Piramal Pharma Solutions Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 142. Piramal Pharma Solutions Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 143. Piramal Pharma Solutions Recent Developments
• Table 144. CPC Scientific Company Information
• Table 145. CPC Scientific Description and Major Businesses
• Table 146. CPC Scientific Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 147. CPC Scientific Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 148. CPC Scientific Recent Developments
• Table 149. Dr. Reddy's Laboratories Company Information
• Table 150. Dr. Reddy's Laboratories Description and Major Businesses
• Table 151. Dr. Reddy's Laboratories Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 152. Dr. Reddy's Laboratories Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 153. Dr. Reddy's Laboratories Recent Developments
• Table 154. Omgene Life Sciences Company Information
• Table 155. Omgene Life Sciences Description and Major Businesses
• Table 156. Omgene Life Sciences Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 157. Omgene Life Sciences Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 158. Omgene Life Sciences Recent Developments
• Table 159. ANYGEN Company Information
• Table 160. ANYGEN Description and Major Businesses
• Table 161. ANYGEN Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 162. ANYGEN Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 163. ANYGEN Recent Developments
• Table 164. BCN Peptides Company Information
• Table 165. BCN Peptides Description and Major Businesses
• Table 166. BCN Peptides Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 167. BCN Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 168. BCN Peptides Recent Developments
• Table 169. Amphastar Pharmaceuticals Company Information
• Table 170. Amphastar Pharmaceuticals Description and Major Businesses
• Table 171. Amphastar Pharmaceuticals Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 172. Amphastar Pharmaceuticals Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
• Table 173. Amphastar Pharmaceuticals Recent Developments
• Table 174. Key Raw Materials Lists
• Table 175. Raw Materials Key Suppliers Lists
• Table 176. Generic Peptides Distributors List
• Table 177. Generic Peptides Customers List
• Table 178. Generic Peptides Market Trends
• Table 179. Generic Peptides Market Drivers
• Table 180. Generic Peptides Market Challenges
• Table 181. Generic Peptides Market Restraints
• Table 182. Research Programs/Design for This Report
• Table 183. Key Data Information from Secondary Sources
• Table 184. Key Data Information from Primary Sources

List of Figures

• Figure 1. Generic Peptides Product Picture
• Figure 2. Global Generic Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Generic Peptides Market Share by Type in 2022 & 2029
• Figure 4. Hormone Analogs Product Picture
• Figure 5. Vasopressin Analogs Product Picture
• Figure 6. Calcitonin Generics Product Picture
• Figure 7. Other Product Picture
• Figure 8. Global Generic Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 9. Global Generic Peptides Market Share by Application in 2022 & 2029
• Figure 10. Commercial Production
• Figure 11. Scientific Research
• Figure 12. Other
• Figure 13. Generic Peptides Report Years Considered
• Figure 14. Global Generic Peptides Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 15. Global Generic Peptides Revenue 2018-2029 (US$ Million)
• Figure 16. Global Generic Peptides Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 17. Global Generic Peptides Revenue Market Share by Region (2018-2029)
• Figure 18. Global Generic Peptides Sales 2018-2029 ((K Units)
• Figure 19. Global Generic Peptides Sales Market Share by Region (2018-2029)
• Figure 20. US & Canada Generic Peptides Sales YoY (2018-2029) & (K Units)
• Figure 21. US & Canada Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
• Figure 22. Europe Generic Peptides Sales YoY (2018-2029) & (K Units)
• Figure 23. Europe Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. China Generic Peptides Sales YoY (2018-2029) & (K Units)
• Figure 25. China Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. Asia (excluding China) Generic Peptides Sales YoY (2018-2029) & (K Units)
• Figure 27. Asia (excluding China) Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. Middle East, Africa and Latin America Generic Peptides Sales YoY (2018-2029) & (K Units)
• Figure 29. Middle East, Africa and Latin America Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
• Figure 30. The Generic Peptides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 31. The Top 5 and 10 Largest Manufacturers of Generic Peptides in the World: Market Share by Generic Peptides Revenue in 2022
• Figure 32. Global Generic Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 33. Global Generic Peptides Sales Market Share by Type (2018-2029)
• Figure 34. Global Generic Peptides Revenue Market Share by Type (2018-2029)
• Figure 35. Global Generic Peptides Sales Market Share by Application (2018-2029)
• Figure 36. Global Generic Peptides Revenue Market Share by Application (2018-2029)
• Figure 37. US & Canada Generic Peptides Sales Market Share by Type (2018-2029)
• Figure 38. US & Canada Generic Peptides Revenue Market Share by Type (2018-2029)
• Figure 39. US & Canada Generic Peptides Sales Market Share by Application (2018-2029)
• Figure 40. US & Canada Generic Peptides Revenue Market Share by Application (2018-2029)
• Figure 41. US & Canada Generic Peptides Revenue Share by Country (2018-2029)
• Figure 42. US & Canada Generic Peptides Sales Share by Country (2018-2029)
• Figure 43. U.S. Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 44. Canada Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 45. Europe Generic Peptides Sales Market Share by Type (2018-2029)
• Figure 46. Europe Generic Peptides Revenue Market Share by Type (2018-2029)
• Figure 47. Europe Generic Peptides Sales Market Share by Application (2018-2029)
• Figure 48. Europe Generic Peptides Revenue Market Share by Application (2018-2029)
• Figure 49. Europe Generic Peptides Revenue Share by Country (2018-2029)
• Figure 50. Europe Generic Peptides Sales Share by Country (2018-2029)
• Figure 51. Germany Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 52. France Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 53. U.K. Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 54. Italy Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 55. Russia Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 56. China Generic Peptides Sales Market Share by Type (2018-2029)
• Figure 57. China Generic Peptides Revenue Market Share by Type (2018-2029)
• Figure 58. China Generic Peptides Sales Market Share by Application (2018-2029)
• Figure 59. China Generic Peptides Revenue Market Share by Application (2018-2029)
• Figure 60. Asia Generic Peptides Sales Market Share by Type (2018-2029)
• Figure 61. Asia Generic Peptides Revenue Market Share by Type (2018-2029)
• Figure 62. Asia Generic Peptides Sales Market Share by Application (2018-2029)
• Figure 63. Asia Generic Peptides Revenue Market Share by Application (2018-2029)
• Figure 64. Asia Generic Peptides Revenue Share by Region (2018-2029)
• Figure 65. Asia Generic Peptides Sales Share by Region (2018-2029)
• Figure 66. Japan Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 67. South Korea Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 68. China Taiwan Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 69. Southeast Asia Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 70. India Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 71. Middle East, Africa and Latin America Generic Peptides Sales Market Share by Type (2018-2029)
• Figure 72. Middle East, Africa and Latin America Generic Peptides Revenue Market Share by Type (2018-2029)
• Figure 73. Middle East, Africa and Latin America Generic Peptides Sales Market Share by Application (2018-2029)
• Figure 74. Middle East, Africa and Latin America Generic Peptides Revenue Market Share by Application (2018-2029)
• Figure 75. Middle East, Africa and Latin America Generic Peptides Revenue Share by Country (2018-2029)
• Figure 76. Middle East, Africa and Latin America Generic Peptides Sales Share by Country (2018-2029)
• Figure 77. Brazil Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 78. Mexico Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 79. Turkey Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 80. Israel Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 81. GCC Countries Generic Peptides Revenue (2018-2029) & (US$ Million)
• Figure 82. Generic Peptides Value Chain
• Figure 83. Generic Peptides Production Process
• Figure 84. Channels of Distribution
• Figure 85. Distributors Profiles
• Figure 86. Bottom-up and Top-down Approaches for This Report
• Figure 87. Data Triangulation
• Figure 88. Key Executives Interviewed